Medicenna Therapeutics (MDNAF, $1.75) was a top weekly loser, falling -1 to $1.75 per share. Of the 895 stocks analyzed in the Biotechnology Industry throughout the week of May 31 - June 7, of them (4) exhibited an Uptrend while of them (5) were in a Downtrend.